Dainippon Sumitomo Changes Drug Name To Avoid Misuse
This article was originally published in PharmAsia News
Executive Summary
Dainippon Sumitomo Pharma has submitted an application to change the name of hypertension drug Almarl (arotinolol) with the Ministry of Health, Labor and Welfare.